COVID-19 and hypertension: is the HSP60 culprit for the severe course and worse outcome?

COVID-19 and the cardiovascular system

(2020) Ying-Ying Zheng et al.   Nature Reviews Cardiology

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Left ventricular hypertrophy is associated with overexpression of HSP60, TLR2, and TLR4 in the myocardium

(2020) Antun Ferenčić et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

COVID-19: is the ACE2 just a foe?

(2020) Hrvoje Jakovac   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19

(2020) Reinhold Kreutz et al.   CARDIOVASCULAR RESEARCH

Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19

(2020) Peng Zhang et al.   CIRCULATION RESEARCH

Estimation of RAAS-Inhibitor effect on the COVID-19 outcome: A Meta-analysis

(2020) Carlos J. Pirola et al.   JOURNAL OF INFECTION

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

(2020) Chaomin Wu et al.   JAMA Internal Medicine

Antihypertensive drugs and risk of COVID-19?

(2020) Christopher J Tignanelli et al.   Lancet Respiratory Medicine

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

(2020) Lei Fang et al.   Lancet Respiratory Medicine

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine

(2020) Vincent Gies et al.   Frontiers in Immunology

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

(2020) George Goshua et al.   Lancet Haematology

SARS-CoV-2 and COVID-19: From the Bench to the Bedside

(2020) Stefano Romagnoli et al.   PHYSIOLOGICAL REVIEWS

Heat shock proteins and cardiovascular disease

(2018) B Rodríguez-Iturbe et al.   Physiology International

Toll-like receptor 4 activation promotes cardiac arrhythmias by decreasing the transient outward potassium current (Ito) through an IRF3-dependent and MyD88-independent pathway

(2014) Gustavo Monnerat-Cahli et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY